2022
DOI: 10.1186/s12879-022-07461-9
|View full text |Cite
|
Sign up to set email alerts
|

Seroprevalence and characteristics of Coronavirus Disease (COVID-19) in workers with non-specific disease symptoms

Abstract: Background The population-based serosurveys are essential for estimating Coronavirus Disease-19 (COVID-19) burden and monitoring the progression of this pandemic. We aimed to assess the seroprevalence of SARS-CoV-2 antibodies and potential predictors of seropositivity in the Pakistani population. Methodology This population-based seroprevalence study includes consenting subjects from the workplaces (factories, corporates, restaurants, media houses,… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
4
1

Citation Types

1
7
0

Year Published

2023
2023
2024
2024

Publication Types

Select...
3
1

Relationship

0
4

Authors

Journals

citations
Cited by 4 publications
(8 citation statements)
references
References 33 publications
1
7
0
Order By: Relevance
“…The overall crude seroprevalence of SARS-CoV-2 was 96.9%, which is consistent with those reported in other settings such as Chile (97.3%) [13]. In contrast, lower seroprevalence values were recently reported in Portugal (2.7-3.9%), Mozambique (3%), Bosnia and [4,[14][15][16][17][18][19][20][21][22][23][24][25][26][27][28][29][30]. Differences in study period, SARS-CoV-2 variants, age groups, prevalence of risk factors and/or comorbidities (e.g., obesity, diabetes, hypertension), and COVID-19 vaccine coverage could explain discrepancies between seroprevalence estimates.…”
Section: Discussionsupporting
confidence: 89%
See 3 more Smart Citations
“…The overall crude seroprevalence of SARS-CoV-2 was 96.9%, which is consistent with those reported in other settings such as Chile (97.3%) [13]. In contrast, lower seroprevalence values were recently reported in Portugal (2.7-3.9%), Mozambique (3%), Bosnia and [4,[14][15][16][17][18][19][20][21][22][23][24][25][26][27][28][29][30]. Differences in study period, SARS-CoV-2 variants, age groups, prevalence of risk factors and/or comorbidities (e.g., obesity, diabetes, hypertension), and COVID-19 vaccine coverage could explain discrepancies between seroprevalence estimates.…”
Section: Discussionsupporting
confidence: 89%
“…In addition, ageusia was the strongest predictor of IgM seropositivity among the patients. Several studies across COVID-19 burden varying settings also reported the clinical utility of COVID-19 evocating clinical symptoms, or more specifically, fever, anosmia, and ageusia [ 15 , 17 , 18 , 20 , 21 , 45 , 47 ]. Ferreira et al .…”
Section: Discussionmentioning
confidence: 99%
See 2 more Smart Citations
“…The Statistics Packages for Social Sciences (SPSS) software (IBM, Armonk, NY, USA) was employed to examine the data to obtain descriptive results and for hypothesis testing. Several authors also used the same software in their study (Brîndescu-Olariu 2016;Javed et al 2022;Poon and Low 2005;Siddiqi et al 2022;Zhou et al 2021). First of all, a Paired T-test was used, where solvency was measured before and after the COVID-19 pandemic to analyze whether COVID-19 affected solvency in restaurants.…”
Section: Methodsmentioning
confidence: 99%